1. Inhibitors of interleukin-1 receptor-associated kinase 4 (IRAK4): a patent review (2012-2015). (2nd August 2016) Authors: Seganish, W. Michael Journal: Expert opinion on therapeutic patents Issue: Volume 26:Number 8(2016:Aug.) Page Start: 917 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Are biosimilars patentable?. (2nd August 2016) Authors: Rolfe, Damian; Parker, Jayson; Morgan, Max Journal: Expert opinion on therapeutic patents Issue: Volume 26:Number 8(2016:Aug.) Page Start: 871 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Azaepothilone B and its derivatives: a patent review. (2nd August 2016) Authors: Mandhare, Anita; Biradar, Satish; Gurule, Asha Journal: Expert opinion on therapeutic patents Issue: Volume 26:Number 8(2016:Aug.) Page Start: 891 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Therapeutic effects of EGCG: a patent review. (2nd August 2016) Authors: Chakrawarti, Leewanshi; Agrawal, Rishab; Dang, Shweta; Gupta, Sanjay; Gabrani, Reema Journal: Expert opinion on therapeutic patents Issue: Volume 26:Number 8(2016:Aug.) Page Start: 907 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Towards selective phosphodiesterase 2A (PDE2A) inhibitors: a patent review (2010 - present). (2nd August 2016) Authors: Trabanco, Andrés A.; Buijnsters, Peter; Rombouts, Frederik J. R. Journal: Expert opinion on therapeutic patents Issue: Volume 26:Number 8(2016:Aug.) Page Start: 933 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Novel compound, organic cation transporter 3 detection agent and organic cation transporter 3 activity inhibitor, WO2015002150 A1: a patent evaluation. (2nd August 2016) Authors: Hu, Tao; Wang, Li; Pan, Xiaolei; Qi, Hualin Journal: Expert opinion on therapeutic patents Issue: Volume 26:Number 8(2016:Aug.) Page Start: 857 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Carbonic anhydrase inhibitors: a review on the progress of patent literature (2011–2016). (2nd August 2016) Authors: Lomelino, Carrie; McKenna, Robert Journal: Expert opinion on therapeutic patents Issue: Volume 26:Number 8(2016:Aug.) Page Start: 947 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Polymers, scaffolds and bioactive molecules with therapeutic properties in osteochondral pathologies: what's new?. (2nd August 2016) Authors: López-Ruiz, Elena; Jiménez, Gema; García, María Ángel; Antich, Cristina; Boulaiz, Houria; Marchal, Juan Antonio; Perán, Macarena Journal: Expert opinion on therapeutic patents Issue: Volume 26:Number 8(2016:Aug.) Page Start: 877 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Sulfoximine substituted quinazolines for pharmaceutical compositions US 20150005278 (A1): a patent evaluation. (2nd August 2016) Authors: Gopaul, Kaalin; Koorbanally, Neil A. Journal: Expert opinion on therapeutic patents Issue: Volume 26:Number 8(2016:Aug.) Page Start: 861 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Therapeutic use of selective synthetic ligands for retinoic acid receptors: a patent review. (2nd August 2016) Authors: Marchwicka, Aleksandra; Cunningham, Alan; Marcinkowska, Ewa; Brown, Geoffrey Journal: Expert opinion on therapeutic patents Issue: Volume 26:Number 8(2016:Aug.) Page Start: 957 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗